The global gastro-retentive drug delivery systems market, valued at USD 14 billion in 2023, is poised for significant growth, with a projected compound annual growth rate (CAGR) of 10.1% from 2023 to 2033. By the end of 2033, the market is expected to reach USD 24.8 billion, according to a recently published report by Future Market Insights.
Key factors driving this expansion include substantial investments by large pharmaceutical companies to enhance gastro-retentive drug delivery systems, as well as the reduction in required doses due to improved bioavailability. These advancements are crucial in addressing the growing demand for more effective medications. The well-established efficacy of GRDDS in treating a range of stomach disorders, including peptic ulcers, gastric ulcers, and H. pylori infections—which can lead to gastritis and gastric cancer—has further accelerated market growth.
GRDDS technology has proven to be instrumental in enhancing the administration of various medicinal substances, improving both bioavailability and therapeutic outcomes. Recent technological advancements have overcome key challenges such as unpredictable stomach emptying periods and short gastric residency times, making it possible for medications to remain in the stomach longer, thus improving absorption.
One of the key benefits of this technology is its ability to increase medication retention time in the stomach, which not only improves patient adherence but also optimizes the therapeutic effect of medications. This extended gastric residency period enables a more controlled and efficient delivery of drugs, particularly for patients suffering from chronic gastrointestinal disorders.
North America is expected to be the largest revenue contributor to the global GRDDS market, with a market projection of USD 10 billion. The region’s growth is driven by the introduction of advanced gastro-retentive drug delivery technologies and the adoption of novel treatment methods in healthcare. With a large patient pool and the growing prevalence of gastrointestinal disorders in the United States and Canada, demand for GRDDS is expected to surge in the coming years. Additionally, increasing research and development spending in emerging markets is expected to contribute to regional market expansion.
The future of the GRDDS market looks promising, with ongoing advancements in controlled oral medication delivery systems poised to overcome physiological barriers and meet the evolving needs of both patients and healthcare providers.
Key Takeaways from the Gastro-retentive Drug Delivery Systems Market Analysis:
- Global Market Overview:
- The Gastro-retentive Drug Delivery Systems (GRDDS) market was valued at USD 14 billion in 2023.
- The market is projected to grow at a CAGR of 10.1% from 2023 to 2033, reaching USD 24.8 billion by the end of the forecast period.
- Regional Market Insights:
- The GRDDS market in the U.S. is expected to grow at a CAGR of 6%, driven by the high prevalence of gastric cancer and increased R&D investments.
- The UK market is forecasted to reach USD 1 billion by 2033, with a CAGR of 6.1%, presenting an absolute dollar opportunity of approximately USD 400 million.
- The market in Japan is anticipated to grow at a CAGR of 7.2%, reaching USD 1 billion by 2033, with an absolute dollar opportunity of USD 500 million.
- The market in South Korea is projected to grow at a CAGR of 7.3%, reaching USD 700 million by 2033, with an expected absolute dollar opportunity of USD 400 million.
These insights reflect significant growth potential in various regions, driven by healthcare needs and ongoing research in gastro-retentive drug delivery technologies.
Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!
Competitive Analysis:
Manufacturers will benefit from proprietary benefits such as industry research financing and product development agreements, which will help them contribute to the development of effective cancer diagnosis technologies. Obtaining patents and government clearances for new technology will also continue to be a key growth strategy. The key players in the market include Ranbaxy, F. Hoffmann La Roche, Pharmacia, GlaxoSmithKline, Lupin, Pfizer, Depomed, Galanix, Sun Pharma, and Alcon, Inc.
Few of the recent developments of key Gastro-retentive Drug Delivery Systems providers are as follows:
- In 2020, Cadila Pharmaceuticals launched Esomeprazole tablets which will be used in treatment of hyperacidity and drug induced gastritis.
- In 2020, Xiromed LLC launched 20mg Omperazole delayed release capsules. Omeprazole is cost effective generic product which can be used in treatment of gastroesophageal reflux disease and healing of erosive esophagitis.
Market Segments Covered in Gastro-retentive Drug Delivery Systems Industry Analysis:
By Type:
- High Density System
- Expandable Drug Delivery System
- Bioadhesive Drug Delivery System
- Floating Drug Delivery System
- Others
By Dosage Form:
- Tablets
- Liquid
- Microspheres
- Capsule
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- APAC
- MEA
𝖤𝗑𝗉𝗅𝗈𝗋𝖾 𝖥𝖬𝖨’𝗌 𝖱𝖾𝗅𝖺𝗍𝖾𝖽 𝖮𝗇𝗀𝗈𝗂𝗇𝗀 𝖢𝗈𝗏𝖾𝗋𝖺𝗀𝖾 𝗈𝗇 𝖧𝖾𝖺𝗅𝗍𝗁𝖼𝖺𝗋𝖾 𝖬𝖺𝗋𝗄𝖾𝗍 𝖨𝗇𝗌𝗂𝗀𝗁𝗍𝗌 𝖣𝗈𝗆𝖺𝗂𝗇:
Transcutaneous Monitors Industry
Pedicle Screw Systems Industry
Stool Management Systems Industry
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube